Yes — diabetes can lead to death through several well-defined pathways, with cardiovascular disease accounting for the majority of fatalities. But the risk is not uniform: how diabetes affects mortality depends on glycemic control, coexisting conditions, and the type of diabetes itself. Here is what the clinical evidence actually shows.
Yes, diabetes can cause death — directly through acute metabolic emergencies like diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), and indirectly through long-term complications, most notably cardiovascular disease, which accounts for roughly two-thirds of deaths in people with diabetes. The World Health Organization attributed approximately 6.7 million deaths globally to diabetes in 2021. However, with aggressive risk-factor management, many of these deaths are preventable.
- How Diabetes Leads to Death: The Core Pathways
- Cardiovascular Disease: The Leading Cause of Death
- Acute Metabolic Emergencies: DKA and HHS
- Chronic Kidney Disease and Renal Failure
- Infections, Cancer, and Other Fatal Complications
- Mortality Data: What the Numbers Actually Say
- Who Carries the Highest Risk?
- Can Diabetes-Related Death Be Prevented?
- When to Seek Emergency Care
- Frequently Asked Questions
How Diabetes Leads to Death: The Core Pathways
Diabetes does not kill by a single mechanism. Instead, it creates a metabolic environment that damages blood vessels, nerves, and organs over years, while also setting the stage for acute crises that can be fatal within hours or days. Understanding these pathways is essential for anyone asking can diabetes cause death — because the answer depends on which pathway you are looking at.
At its core, diabetes is a disorder of glucose regulation. In type 1 diabetes, the immune system destroys the pancreatic beta cells that produce insulin, leaving the body unable to move glucose into cells for energy. In type 2 diabetes, the body becomes resistant to insulin, and eventually the pancreas cannot produce enough to compensate. Both scenarios lead to chronic hyperglycemia — persistently high blood sugar — which inflicts damage on endothelial cells lining every blood vessel in the body.[1]
From here, death can occur through several routes:
- Atherosclerotic cardiovascular disease — accelerated plaque formation in coronary and cerebral arteries leads to heart attack and stroke.
- Microvascular damage — in the kidneys, this causes diabetic nephropathy and eventual renal failure; in the eyes, it causes blindness; in peripheral nerves, it causes neuropathy that can lead to limb-threatening infections.
- Acute metabolic decompensation — severely high or low blood glucose can push the body into DKA, HHS, or severe hypoglycemia, each of which can be rapidly fatal without intervention.
- Immute dysfunction — chronic hyperglycemia impairs neutrophil and macrophage function, increasing susceptibility to serious infections that can become fatal.
Cardiovascular Disease: The Leading Cause of Death
Cardiovascular disease (CVD) is, by a wide margin, the most common cause of death in people with diabetes. Adults with diabetes have a two- to four-fold higher risk of dying from heart disease compared to those without diabetes, independent of other traditional risk factors.[2] The American Heart Association considers diabetes a cardiovascular risk equivalent — meaning a person with diabetes without prior heart disease has a similar risk of a future cardiac event as someone who has already had a heart attack.
Chronic hyperglycemia accelerates atherosclerosis through several interconnected mechanisms. Advanced glycation end-products (AGEs) form when glucose binds to proteins and lipids in vessel walls, triggering inflammatory cascades that promote plaque formation. Oxidative stress increases, reducing the availability of nitric oxide and impairing the ability of arteries to dilate. The result is a pro-thrombotic, pro-inflammatory vascular environment that narrows arteries and makes blood clots more likely.
The specific cardiovascular events that kill most frequently are:
- Myocardial infarction (heart attack) — often silent or atypical in people with diabetes due to autonomic neuropathy, which can delay treatment.
- Stroke — ischemic stroke risk is increased 1.5- to 3-fold, and outcomes are worse in the presence of hyperglycemia.
- Heart failure — even in the absence of coronary artery disease, diabetes can cause diabetic cardiomyopathy, a direct impairment of heart muscle function.
The good news is that aggressive management of blood pressure, LDL cholesterol, and glycemic control significantly reduces cardiovascular mortality. The landmark UK Prospective Diabetes Study (UKPDS) showed that each 1% reduction in A1C was associated with a 21% reduction in diabetes-related deaths and a 14% reduction in myocardial infarction over 10 years.[3]
Acute Metabolic Emergencies: DKA and HHS
While cardiovascular death is a long-term risk, acute metabolic emergencies can kill in hours to days. These are the direct answer to the question "can diabetes cause death quickly?" — and the answer is yes, through diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS).
Diabetic Ketoacidosis (DKA)
DKA occurs primarily in type 1 diabetes but can also affect people with type 2 during severe illness or stress. Without enough insulin, the liver begins breaking down fat for energy, producing ketone bodies — acetone, acetoacetate, and beta-hydroxybutyrate — that acidify the blood. The classic triad is hyperglycemia, metabolic acidosis, and ketosis. Untreated DKA leads to cerebral edema, cardiac arrhythmia, and death. With proper treatment, the mortality rate is less than 1% in experienced centers, but it rises to 5–10% in older adults or those with severe concurrent illness.[4]
Hyperosmolar Hyperglycemic State (HHS)
HHS is more common in type 2 diabetes, typically in older adults. Extreme hyperglycemia (often above 600 mg/dL) causes severe osmotic diuresis — the kidneys excrete massive amounts of glucose and water, leading to profound dehydration, electrolyte imbalances, and altered mental status. Mortality from HHS is significantly higher than DKA, ranging from 10% to 20%, largely because it tends to occur in older, frailer patients with multiple comorbidities.[4]
Severe hypoglycemia is the third acute emergency. Insulin or sulfonylurea excess can drive blood glucose dangerously low, causing seizures, loss of consciousness, and death if not corrected. Hypoglycemia-related mortality is especially concerning overnight during sleep, which is why continuous glucose monitors with alarms are now recommended for anyone at elevated risk.[1]
Chronic Kidney Disease and Renal Failure
Diabetes is the leading cause of end-stage kidney disease (ESKD) worldwide, accounting for approximately 40–50% of all new dialysis starts in the United States.[2] The progression from microalbuminuria to overt nephropathy to renal failure can take 10–20 years, but once the estimated glomerular filtration rate (eGFR) drops below 30 mL/min/1.73m², the risk of death exceeds the risk of progression to dialysis itself.
Kidney failure kills through a combination of fluid overload (pulmonary edema), electrolyte disturbances (especially hyperkalemia leading to cardiac arrest), uremic toxins that impair every organ system, and the dramatically amplified cardiovascular risk that accompanies declining kidney function. People with diabetic nephropathy are far more likely to die from a cardiovascular event than to reach ESKD, which is why kidney protection is a core cardiovascular strategy. Sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have been shown to slow kidney disease progression and reduce cardiovascular mortality in people with type 2 diabetes and chronic kidney disease.[5]
Infections, Cancer, and Other Fatal Complications
Beyond cardiovascular and kidney disease, diabetes contributes to death through several additional mechanisms that are often underappreciated.
Serious infections are a major cause of hospitalizations and death. Hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and bacterial killing. People with diabetes have significantly higher rates of pneumonia, urinary tract infections, skin and soft tissue infections, and sepsis. Post-surgical infection rates are elevated, and once an infection takes hold, the risk of progression to septic shock is higher. Influenza and COVID-19 mortality are both substantially increased in the presence of diabetes.[6]
Cancer risk is also elevated. Epidemiologic data show a 20–30% higher incidence of several cancers — including pancreatic, liver, colorectal, endometrial, and breast — in people with type 2 diabetes. The mechanisms are not fully understood but likely involve hyperinsulinemia, insulin-like growth factor signaling, and chronic inflammation. Cancer mortality is also higher in people with diabetes, partly because of delayed diagnosis and partly because comorbidities may limit treatment options.[2]
Lower-extremity amputation is a devastating complication that carries high post-surgical mortality. Peripheral arterial disease combined with neuropathy leads to non-healing ulcers, gangrene, and eventual amputation. The five-year mortality rate after a diabetes-related lower-extremity amputation is approximately 50–70% — worse than many cancers — due to the combination of cardiovascular disease, infection, and loss of mobility.[7]
Mortality Data: What the Numbers Actually Say
Cold statistics can feel abstract, but they provide an essential answer to the question "can diabetes cause death" with real scale. Globally, the World Health Organization reported that diabetes was the direct cause of approximately 1.5 million deaths in 2019, and contributed to an additional 4.2 million deaths from cardiovascular and kidney disease — bringing the total attributable burden to over 5.7 million.[8]
In the United States, the CDC National Diabetes Statistics Report lists diabetes as the eighth leading cause of death, with roughly 100,000 death certificates per year listing diabetes as the underlying cause. But death certificates notoriously undercount diabetes as a cause of death — when diabetes is listed as a contributing factor, the number exceeds 300,000 annually.[6]
| Population | Annual Mortality Estimate | Primary Source |
|---|---|---|
| Global (direct diabetes deaths) | ~1.5 million | WHO 2021 |
| Global (attributable — CVD + kidney) | ~4.2 million additional | WHO / IDF 2021 |
| United States (underlying cause) | ~100,000 | CDC 2023 |
| United States (contributing cause) | ~300,000+ | CDC 2023 |
| Relative risk — CVD death (diabetes vs. no diabetes) | 2- to 4-fold | AHA / ADA |
| Relative risk — all-cause death (diabetes vs. no diabetes) | ~1.5- to 2-fold | CDC / ADA |
The takeaway from these numbers is clear: most diabetes-related deaths are not from hyperglycemia alone but from the downstream vascular damage it causes. The good news is that the gap in life expectancy between people with diabetes and those without has narrowed over the past two decades, particularly in younger populations, due to better risk-factor management and earlier diagnosis.[9]
Who Carries the Highest Risk?
Not everyone with diabetes faces the same mortality risk. Several factors substantially increase the likelihood of a fatal outcome.
Poor glycemic control (persistently high A1C)
Every 1% increase in A1C above 7% is associated with a 15–20% increase in the relative risk of all-cause mortality. The relationship is continuous — there is no threshold below which risk plateaus entirely. People with A1C values consistently above 9% have approximately double the mortality risk compared to those maintaining A1C below 7%.[3]
Long diabetes duration
Duration of diabetes is an independent risk factor for death, separate from current glycemic control. Someone diagnosed with type 2 diabetes at age 40 who has had the condition for 20 years has a significantly higher cumulative risk than someone diagnosed at age 60 with the same current A1C. The damage from hyperglycemia accumulates over time — a phenomenon known as "metabolic memory."
Presence of cardiovascular or kidney disease
Established CVD or CKD dramatically amplifies mortality risk. People with diabetes and heart failure have a five-year mortality rate exceeding 50%. Those with ESKD on dialysis have an annual mortality rate of approximately 15–20%, with cardiovascular events accounting for the majority of deaths. The combination of reduced eGFR and elevated albuminuria carries a particularly steep gradient of risk.[5]
Social determinants of health
Mortality from diabetes is two to three times higher in lower-income populations and in communities with limited access to healthcare, healthy food, and diabetes education. In the U.S., Black and Hispanic adults with diabetes have higher rates of ESKD, amputation, and diabetes-related death compared with White adults, even after adjusting for age and disease duration. These disparities reflect systemic barriers to care, not biological differences.[6]
Younger age at onset (especially for type 2)
People diagnosed with type 2 diabetes before age 40 face a disproportionately higher lifetime risk of complications and death because they live with metabolic dysfunction for more decades. A 2020 study in the UK found that each decade earlier of type 2 diabetes diagnosis was associated with a 1.3-fold higher risk of all-cause mortality. Early-onset type 2 diabetes is an aggressive phenotype that demands intensive therapy.[9]
Can Diabetes-Related Death Be Prevented?
This is the question that follows naturally from "can diabetes cause death" — and the clinical evidence is clear: the majority of diabetes-related deaths are preventable through consistent, evidence-based care. The key pillars of prevention are straightforward in concept, though they require sustained effort in practice.
Glycemic control is necessary but not sufficient
The ADA recommends a target A1C below 7% for most non-pregnant adults, though individualized targets depend on age, life expectancy, and comorbidity burden. The ACCORD trial showed that attempting to push A1C below 6% with intensive therapy actually increased mortality in high-risk older adults, so aggressive lowering is not always better.[1] The sweet spot for most adults is an A1C in the 6.5–7.5% range, achieved without causing frequent hypoglycemia.
Blood pressure management is arguably more impactful
Elevated blood pressure kills people with diabetes faster than elevated glucose alone. The ADA recommends a target blood pressure below 130/80 mmHg for most adults with diabetes. The SPRINT trial and subsequent analyses showed that intensive systolic blood pressure lowering (to less than 120 mmHg) reduces cardiovascular events and all-cause mortality in high-risk populations, including those with diabetes. ACE inhibitors, ARBs, thiazide diuretics, and calcium channel blockers all have evidence supporting their use.[2]
Lipid management with statins is standard of care
The American Heart Association recommends moderate- to high-intensity statin therapy for nearly all adults with diabetes aged 40–75, regardless of baseline LDL cholesterol levels, because the risk is high enough to merit treatment. Statins have been shown to reduce major cardiovascular events by approximately 25% in people with diabetes, translating into significant mortality reduction.[2]
Organ-protective medications change the game
Over the past decade, two drug classes have emerged that reduce mortality independently of their glucose-lowering effects. SGLT2 inhibitors (empagliflozin, dapagliflozin) and GLP-1 receptor agonists (liraglutide, semaglutide) have each been shown in large cardiovascular outcomes trials to reduce cardiovascular death, heart failure hospitalizations, and all-cause mortality in people with type 2 diabetes and established CVD or high cardiovascular risk. The EMPA-REG OUTCOME trial, for example, found a 38% relative risk reduction in cardiovascular death with empagliflozin.[5]
Lifestyle factors still matter profoundly
A Mediterranean-style diet, regular physical activity (at least 150 minutes per week of moderate-intensity exercise), smoking cessation, and maintaining a healthy body weight all reduce mortality independently of medication. The combination of these interventions is more powerful than any single one alone.[7]
A 55-year-old with type 2 diabetes, an A1C of 7.8%, blood pressure 138/86, and LDL 110 mg/dL who starts a moderate-intensity statin, an SGLT2 inhibitor, adopts a Mediterranean diet, and walks 30 minutes daily can realistically reduce their absolute risk of death over the next decade from approximately 15–20% down to 8–12%. That is a clinically meaningful reduction — roughly one in ten lives saved.
When to Seek Emergency Care
Part of the answer to "can diabetes cause death" is recognizing the moment when risk shifts from chronic to acute. Certain signs and symptoms signal that a person with diabetes needs immediate medical attention, not a scheduled clinic visit.
If you are unsure whether symptoms warrant emergency care, err on the side of seeking it. The mortality risk from delaying is far greater than the inconvenience of a negative evaluation.
Frequently Asked Questions
Can you die suddenly from diabetes?
Yes, sudden death can occur in diabetes through several mechanisms. Severe hypoglycemia can cause cardiac arrhythmias or seizures that lead to death within minutes, particularly during sleep ("dead-in-bed" syndrome in type 1 diabetes). Acute DKA or HHS can cause fatal cerebral edema or cardiac arrest within hours to a day if untreated. And the first manifestation of cardiovascular disease in a person with diabetes can be a fatal heart attack or stroke with no prior warning signs. These are not common, but they are real risks — which is why symptom recognition matters.
What is the most common cause of death in people with diabetes?
Cardiovascular disease — including heart attack, stroke, and heart failure — is the leading cause of death, responsible for approximately 65% of all deaths in the diabetes population. This is followed by chronic kidney disease, infections (especially pneumonia and sepsis), and cancer. Acute metabolic emergencies (DKA and HHS) account for a smaller percentage but are the most common cause of death in younger people with type 1 diabetes.[2]
Does type 1 or type 2 diabetes have a higher mortality rate?
Type 1 diabetes carries a higher relative mortality at younger ages — people with type 1 lose approximately 11–13 years of life expectancy compared to the general population, largely due to acute metabolic crises and early cardiovascular disease. Type 2 diabetes, because it is far more common (90–95% of all diabetes), accounts for many more total deaths, and the absolute life expectancy reduction is smaller (approximately 5–10 years) but the population burden is enormous. Early diagnosis and intensive risk-factor management narrow the gap for both types.[9]
Can diabetes be cured so that it no longer causes death?
There is no cure for diabetes, but type 2 diabetes can be put into durable remission — defined as an A1C below 6.5% without glucose-lowering medication for at least one year — through substantial weight loss (typically 15% or more of body weight, achieved via bariatric surgery or intensive lifestyle intervention). In remission, the excess mortality risk associated with diabetes is substantially reduced, though some residual risk may persist depending on how long the person had diabetes before remission. For type 1 diabetes, insulin therapy is lifesaving but there is no remission pathway; the focus is on risk minimization.[1]
How long can you live after a diabetes diagnosis?
Life expectancy after a diabetes diagnosis varies dramatically based on the age at diagnosis, glycemic control, cardiovascular risk factors, and the presence of complications. A 50-year-old diagnosed with type 2 diabetes who achieves good control (A1C below 7%, blood pressure below 130/80, LDL below 100 mg/dL, non-smoker) can expect to live an additional 25–30 years — similar to a person without diabetes. In contrast, a 50-year-old with poor control, smoking, and established cardiovascular disease may have a life expectancy of only 10–15 more years. Diabetes does not have to shorten life, but it demands active management to prevent that outcome.[9]
- Diabetes can cause death through cardiovascular disease (most common), acute metabolic emergencies like DKA/HHS, kidney failure, severe infections, and complications such as lower-extremity amputation.
- Cardiovascular disease accounts for roughly two-thirds of deaths in people with diabetes; aggressive blood pressure, lipid, and glycemic management are the most effective preventive strategies.
- Acute metabolic emergencies — DKA and HHS — can be fatal within hours to days, with mortality rates of 1–5% for DKA and 10–20% for HHS. Prompt recognition and treatment save lives.
- SGLT2 inhibitors and GLP-1 receptor agonists reduce cardiovascular and all-cause mortality independent of glucose-lowering, making them cornerstone therapies for high-risk individuals.
- Type 1 diabetes carries higher relative mortality at younger ages; type 2 accounts for the majority of total deaths due to its prevalence. Both are associated with a 1.5- to 2-fold increase in all-cause mortality compared to the general population.
- With optimal modern care — including glycemic targets, statins, blood pressure control, and organ-protective medications — most excess mortality in diabetes can be reduced or eliminated.
- American Diabetes Association. Standards of Care in Diabetes — 2025. Diabetes Care. 2025;48(Suppl 1).
- American Heart Association / American College of Cardiology. Guideline for the Management of Blood Cholesterol and Cardiovascular Risk in Diabetes. 2024.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352(9131):837–853.
- Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensation in diabetes. J Clin Endocrinol Metab. 2022;107(6):1553–1565.
- Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–2128.
- Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2024. Atlanta, GA: CDC; 2024.
- American Diabetes Association. Standards of Medical Care in Diabetes — 2025. Chapter 12: Foot Care and Lower-Extremity Complications.
- World Health Organization. Global Report on Diabetes, 2021 Update. Geneva: WHO; 2021.
- Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841.
